NO20005628L - Fremgangsmåte for utvelgelse av et virus - Google Patents

Fremgangsmåte for utvelgelse av et virus

Info

Publication number
NO20005628L
NO20005628L NO20005628A NO20005628A NO20005628L NO 20005628 L NO20005628 L NO 20005628L NO 20005628 A NO20005628 A NO 20005628A NO 20005628 A NO20005628 A NO 20005628A NO 20005628 L NO20005628 L NO 20005628L
Authority
NO
Norway
Prior art keywords
virus
polypeptide
fusion
selecting
propagating
Prior art date
Application number
NO20005628A
Other languages
English (en)
Other versions
NO20005628D0 (no
NO329172B1 (no
Inventor
Lutz Riechmann
Peter Kristensen
Jean-Luc Jestin
Gregory Paul Winter
Original Assignee
Diversys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810228.8A external-priority patent/GB9810228D0/en
Priority claimed from GBGB9810223.9A external-priority patent/GB9810223D0/en
Application filed by Diversys Ltd filed Critical Diversys Ltd
Publication of NO20005628D0 publication Critical patent/NO20005628D0/no
Publication of NO20005628L publication Critical patent/NO20005628L/no
Publication of NO329172B1 publication Critical patent/NO329172B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Saccharide Compounds (AREA)
  • Vehicle Body Suspensions (AREA)
  • Circuits Of Receivers In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Air Bags (AREA)
NO20005628A 1998-05-13 2000-11-08 Fremgangsmate for seleksjon av et korrekt foldet fusjonspolypeptid NO329172B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9810228.8A GB9810228D0 (en) 1998-05-13 1998-05-13 Selection method
GBGB9810223.9A GB9810223D0 (en) 1998-05-13 1998-05-13 Selection system
PCT/GB1999/001526 WO1999058655A2 (en) 1998-05-13 1999-05-13 Phage display selection system for folded proteins

Publications (3)

Publication Number Publication Date
NO20005628D0 NO20005628D0 (no) 2000-11-08
NO20005628L true NO20005628L (no) 2001-01-12
NO329172B1 NO329172B1 (no) 2010-09-06

Family

ID=26313668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005628A NO329172B1 (no) 1998-05-13 2000-11-08 Fremgangsmate for seleksjon av et korrekt foldet fusjonspolypeptid

Country Status (14)

Country Link
US (2) US7442159B1 (no)
EP (2) EP1950295A1 (no)
JP (2) JP4493846B2 (no)
AT (1) ATE380865T1 (no)
AU (1) AU762814B2 (no)
CA (1) CA2328422A1 (no)
CY (1) CY1107293T1 (no)
DE (1) DE69937735T2 (no)
DK (1) DK1078051T3 (no)
ES (1) ES2299244T3 (no)
GB (1) GB2361237A (no)
NO (1) NO329172B1 (no)
PT (1) PT1078051E (no)
WO (1) WO1999058655A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006717A2 (en) 1998-07-27 2000-02-10 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
PT1144607E (pt) 1999-07-20 2009-04-22 Morphosys Ag Novos métodos para apresentar (poli)peptídeos/ proteínas em partículas bacteriofágicas através de ligações dissulfureto
WO2001057065A2 (en) * 2000-02-03 2001-08-09 Domantis Limited Combinatorial protein domains
GB0019049D0 (en) * 2000-08-04 2000-09-27 Neutec Pharma Plc Combinatorial chemistry method
WO2002012277A2 (en) * 2000-08-07 2002-02-14 Domantis Limited Hybrid combinatorial proteins made from reshuffling of differently folded domains
DE10135039C1 (de) * 2001-07-18 2003-03-13 Nemod Immuntherapie Ag Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
EP2357237A1 (en) 2003-05-14 2011-08-17 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
US8846577B2 (en) * 2005-07-08 2014-09-30 University Of Zurich Phage display using cotranslational translocation of fusion polypeptides
GB2428293A (en) * 2005-07-13 2007-01-24 Domantis Ltd Phage display libraries
ATE524579T1 (de) 2005-07-21 2011-09-15 Aebi Ltd Verfahren und zusammensetzungen zur identifizierung eines peptids mit intermolekularer wechselwirkung mit einem interessierenden ziel
GB0515115D0 (en) 2005-07-22 2005-08-31 Isogenica Ltd Peptide characterisation
DK2032701T3 (da) * 2006-06-23 2014-02-10 Alethia Biotherapeutics Inc Polynukleotider og polypeptider, der er inddraget i cancer
EA200901494A1 (ru) 2007-06-06 2010-06-30 Домантис Лимитед Способы селекции протеазоустойчивых полипептидов
EP2190987B1 (en) 2007-08-21 2012-11-14 MorphoSys AG Methods for the formation of disulphide bonds
CN104650235A (zh) 2007-11-30 2015-05-27 葛兰素集团有限公司 抗原结合构建体
KR20110084280A (ko) 2008-11-03 2011-07-21 알레시아 바이오쎄라퓨틱스 인코포레이티드 종양 항원의 생물 활성을 특이적으로 차단하는 항체
AU2009324037B2 (en) 2008-12-05 2015-07-30 Glaxo Group Limited Methods for selecting protease resistant polypeptides
WO2010097385A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
JP2012518400A (ja) 2009-02-24 2012-08-16 グラクソ グループ リミテッド 多価および／または複数特異的ｒａｎｋｌ結合性構築物
WO2010097386A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
JP2014501725A (ja) 2010-11-24 2014-01-23 グラクソ グループ リミテッド Ｈｇｆを標的とする多特異的抗原結合タンパク質
KR101993259B1 (ko) 2011-03-31 2019-06-27 에이디씨 테라퓨틱스 에스에이 신장 결합 항원 １에 대한 항체 및 이의 항원 결합 단편
US9499612B2 (en) 2011-07-27 2016-11-22 Glaxo Group Limited Antigen binding constructs
US9624523B2 (en) 2011-10-27 2017-04-18 The Governors Of The University Of Alberta Device and method for bacterial culture and assay
EA201992513A1 (ru) 2012-01-09 2020-05-31 Адс Терапьютикс Са Способ лечения рака груди
US20150087810A1 (en) * 2013-09-25 2015-03-26 Cytomx Therapeutics, Inc. Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof
EP4176896A1 (en) 2014-01-31 2023-05-10 Cytomx Therapeutics Inc. Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
EP3218479A1 (en) * 2014-11-11 2017-09-20 Nanocore ApS Method for identification of molecules with desired characteristics
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
CA2981098A1 (en) * 2015-03-31 2016-10-06 Vhsquared Limited Peptide construct having a protease-cleavable linker
US12049505B2 (en) 2018-12-06 2024-07-30 Cytomx Therapeutics, Inc. Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof
US20220228172A1 (en) * 2019-06-21 2022-07-21 Boehringer Ingelheim International Gmbh Novel Mechanism to Control RNA Virus Replication and Gene Expression

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
JPH06508511A (ja) * 1990-07-10 1994-09-29 ケンブリッジ　アンティボディー　テクノロジー　リミティド 特異的な結合ペアーの構成員の製造方法
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK1279731T3 (da) * 1991-03-01 2007-09-24 Dyax Corp Fremgangsmåde til udvikling af bindende miniproteiner
DE4122599C2 (de) * 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ES2313867T3 (es) 1991-12-02 2009-03-16 Medical Research Council Produccion de anticuerpos anti-auto de repertorios de segmentos de anticuerpo expresados en la superficie de fagos.

Also Published As

Publication number Publication date
NO20005628D0 (no) 2000-11-08
EP1950295A1 (en) 2008-07-30
US7442159B1 (en) 2008-10-28
ATE380865T1 (de) 2007-12-15
GB0026143D0 (en) 2000-12-13
AU3941399A (en) 1999-11-29
CY1107293T1 (el) 2012-11-21
US20090203542A1 (en) 2009-08-13
WO1999058655A3 (en) 2000-01-27
EP1078051B1 (en) 2007-12-12
JP2010148507A (ja) 2010-07-08
ES2299244T3 (es) 2008-05-16
JP2002514413A (ja) 2002-05-21
NO329172B1 (no) 2010-09-06
AU762814B2 (en) 2003-07-03
PT1078051E (pt) 2008-03-17
EP1078051A2 (en) 2001-02-28
JP5161865B2 (ja) 2013-03-13
DE69937735T2 (de) 2008-11-27
DE69937735D1 (de) 2008-01-24
GB2361237A (en) 2001-10-17
WO1999058655A2 (en) 1999-11-18
JP4493846B2 (ja) 2010-06-30
US8680018B2 (en) 2014-03-25
CA2328422A1 (en) 1999-11-18
DK1078051T3 (da) 2008-04-07

Similar Documents

Publication Publication Date Title
NO20005628D0 (no) Fremgangsmåte for utvelgelse av et virus
DK0816506T3 (da) System til ekspression af heterologe antigener som fusionsproteiner
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
DK2025753T3 (da) Fagmid til screening af antistoffer
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
HK1038244A1 (en) A method for the high level expression of the active form of lymphotoxin- beta receptor immunoglobulin fusion proteins and their purification
DE69633563D1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
DK0977873T3 (da) Fremgangsmåde til spaltning af fusionsproteiner
IS6678A (is) Hvarfefni og prófanir fyrir ß-sekretasavirkni
ID24590A (id) Metode dan komposisi untuk pembuatan lensa oftalmil berwarna
WO2000031127A3 (en) Protein fragments for use in protein targeting
ATE294237T1 (de) S?ugetier thymokingene
DE69611896D1 (de) Fusions-DNS-Sequenz, dadurch exprimiertes Fusionsprotein und Verfahren zur Expression dieses Fusionsproteins
DK0829579T3 (da) Farbart bindelag og fremgangsmåde til den fremstilling
WO2000034335A3 (en) 'death domain' containing receptors
DK0786476T3 (da) Sammensætning og fremgangsmåde til limning af plane strukturer
DE69803762D1 (de) Verfahren zur herstellung von abgeschlossenen gasbehältern
US5807733A (en) Mammalian prostaglandin H synthase-2 fusion proteins

Legal Events

Date Code Title Description
MK1K Patent expired